InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Friday, 02/20/2015 9:30:40 AM

Friday, February 20, 2015 9:30:40 AM

Post# of 80868
The stock is undervalued right now, considering the availability of Musclepharm's powder products and the promise of wider scale launches of protein bars and RTD products down the road.

Dilution, expensive under performing endorsements and lack of profitability is the worry among investors.

Investors should cheer those endorsements that do give a decent return like Arnold Schwarzenegger that is currently selling wide, through specialty and big box retailer (and where specially designed Arnold Schwarzenegger bodybuilding apparel might gross millions).
Furthermore, Musclepharm is close to breaking even....and it doesn't have much debt.....so, there shouldn't be that much worry about the company going down before it hits critical mass.

Dilution should be expected to be minimal going forward as the stock price is under pressure following some bad news and lots of stock bashing for the last 4 years....and there is no need for major investments in endorsers or payment of employees above industry averages.
There is only 1 million shares left for employees, and they will be spread over some years.


So, really...it's about waiting for critical mass being reached, similar to waiting for christmas to get your year-end bonus.